11.11.2021 • NewsBASFSolenis

Sale of Solenis to Platinum Equity Closes

With the receipt of all approvals, BASF and Clayton, Dubilier & Rice (CD&R) have closed the sale of water treatment company Solenis to Platinum Equity. The transfer to the new private equity investor for an enterprise value of $5.25 billion includes net debt of around $2.5 billion.

The buyer and sellers announced the deal this past July. At the time of sale, BASF held 49% of the two-year-old company, the investment group 51%, together with Solenis’ management.

The ownership structure emerged from CD&R’s $1.8 billion purchase of the water chemicals unit of US chemical producer Ashland in 2018. In 2019, the German group folded its water chemicals business into the new business.

BASF said the divestment of its shares in Solenis will be reflected in its financial reporting for the current fourth quarter as net income from shareholdings.

With more than 5,200 employees, Solenis produces mainly specialty chemicals used in water treatment and paper manufacturing. It also makes products for other water-intensive industries including chemical processing, mining and oil production. The Wilmington, Delaware-based US company reported sales of $ 3billion for fiscal year 2021 (Sept. 30).

Author: Dede Williams, Freelance Journalist

With receipt of all approvals, BASF and Clayton, Dubilier & Rice have closed...
With receipt of all approvals, BASF and Clayton, Dubilier & Rice have closed the sale of water treatment company Solenis to Platinum Equity. The transfer to the new private equity investor for an enterprise value of $5.25 million includes net debt of around $2.5 billion. (c) Solenis

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.